Analogic
Generated 5/11/2026
Executive Summary
Analogic Corporation is a privately held innovator in medical imaging and security screening technologies. Founded in 1967 and headquartered in Peabody, Massachusetts, the company develops enabling subsystems for computed tomography (CT), digital mammography (DM), and magnetic resonance imaging (MRI), as well as advanced threat detection systems for airport baggage screening. With over 50 years of engineering expertise, Analogic has established a reputation for delivering cost-effective, time-saving solutions that improve patient outcomes and enhance security. The company's technologies are embedded in leading medical devices and security scanners globally, positioning it as a key supplier in regulated industries. Despite strong market presence, Analogic remains private, and its growth is driven by long-standing OEM relationships and continuous innovation. The company faces competition from larger players but leverages its deep domain knowledge and reliability to maintain relevance. As healthcare and security demands evolve, Analogic is well-positioned to capitalize on trends such as early disease detection and advanced security threats, though its private status limits visibility into financials.
Upcoming Catalysts (preview)
- Q3 2026New FDA 510(k) clearance for next-generation CT subsystem80% success
- Q4 2026Partnership with major airport security integrator for checked-baggage screening upgrade60% success
- TBDExpansion into emerging market MRI components through strategic joint venture50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)